Announcements Trials
Browse Landscape

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 286Observational 3

Sponsor

Cancer Type

Genitourinary 19Breast 6Head & Neck 5Thoracic 4Gastrointestinal 3Tumor-Agnostic 1Other 1Gynecologic 1

Conditions

Stomach Neoplasms 2Colonic Neoplasms 2Pancreatic Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 80Surgical Procedures, Operative 53Observation 44Drug Therapy 44Colonoscopy 41Bevacizumab 41Biopsy 35Hepatectomy 33Capecitabine 27Neoadjuvant Therapy 26Immune Checkpoint Inhibitors 26regorafenib 25Interviews as Topic 25Radiotherapy 24Oxaliplatin 24Sorafenib 22Magnetic Resonance Spectroscopy 22lenvatinib 21Endoscopic Mucosal Resection 21Specimen Handling 18Immunohistochemistry 18Endoscopy 18Pancreaticoduodenectomy 17Liquid Biopsy 17Gastrectomy 17Endoscopic Ultrasound-Guided Fine Needle Aspiration 17Tomography, X-Ray Computed 16Gastroscopy 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Docetaxel × Gastrointestinal × Clear all
NCT03001726 2022-05-06

To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.

Shanghai Zhongshan Hospital

Unknown
228 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03668418 2018-09-12

xenoZ

University of Pisa

Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02479217 2017-02-17

Safety of Xeloda in Solid Tumours

Hoffmann-La Roche

Completed
1,268 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡